纤维细胞生长因子23相关的低酸性乱的最新进展
Yuichi Takashi1, Daiji Kawanami1, Seiji Fukumoto2
1Department of Endocrinology and Diabetes, Fukuoka University School of Medicine.
Current opinion in endocrinology, diabetes, and obesity
|April 30, 2024
概括
纤维细胞生长因子23 (FGF23) 是一种影响酸盐水平的激素. 像布罗苏马布这样的新疗法对与FGF23相关的低酸性乱有前途,改善了风和骨质疏松症的症状.
科学领域:
- 内分泌学 在内分泌学.
- 矿物质的新陈代谢.
- 遗传学 是一个遗传学.
背景情况:
- 纤维细胞生长因子23 (FGF23) 调节酸盐稳态.
- 过度的FGF23活性会导致低酸性疾病,如X链接的低酸性狂风病 (XLH) 和瘤诱导的骨质疏松症 (TIO).
研究的目的:
- 审查最近在诊断和治疗与FGF23相关的低酸性疾病方面的进展.
- 为了突出准确FGF23测量在诊断中的重要性.
主要方法:
- 关于FGF23疾病的当前文献的综述.
- 分析FGF23血液水平的诊断效用.
- 对治疗策略的评估,包括布罗苏马布.
主要成果:
- 测量FGF23的血液水平对于诊断这些疾病至关重要.
- 许多患者,特别是TIO患者,面临误诊,需要提高疾病意识.
- 针对FGF23的单克隆抗体布罗苏马布 (Burosumab) 已获得批准,并显示了长期改善拉基茨/骨质疏松症的生物化学和临床结果.
结论:
- 需要进一步的长期研究才能充分了解布罗苏马布的作用.
- 需要澄清受影响患者FGF23过度产生的机制.
相关概念视频
Roles of Electrolytes: Calcium and Phosphate
257
Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
The calcium concentration in blood plasma is primarily...
257
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
159
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
159
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


